Dan Thomas's most recent trade in MDB Capital Holdings LLC - Ordinary Shares - Class A was a trade of 10,000 RSU done . Disclosure was reported to the exchange on Feb. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MDB Cap Holdings LLC (Class A) | Daniel Thomas Torpey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2026 | 10,000 | 70,000 | - | - | RSU | |
| MDB Cap Holdings LLC (Class A) | Daniel Thomas Torpey | Director | Grant, award, or other acquisition of securities at price $ 3.20 per share. | 09 Feb 2026 | 10,000 | 37,100 | - | 3.2 | 32,000 | Common Stock |
| Concentra Grp Holdings Parent Inc | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2025 | 7,748 | 74,000 | - | 0 | Common Stock | |
| Select Medical Holdings Corp | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2025 | 14,035 | 80,035 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 115,000 | 115,000 | - | - | Stock Option (Right to Buy) | |
| T-Mobile US | Thomas Dannenfeldt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 1,038 | 1,038 (0%) | 0% | 0 | Common Stock | |
| Concentra Grp Holdings Parent Inc | Daniel Thomas J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 6,496 | 59,796 | - | 0 | Common Stock | |
| Concentra Grp Holdings Parent Inc | Thomas J. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2024 | 6,496 | 66,252 | - | 0 | Common Stock | |
| Concentra Grp Holdings Parent Inc | Daniel J. Thomas | Director | Other type of transaction at price $ 0.00 per share. | 25 Nov 2024 | 53,260 | 53,260 | - | 0 | Common Stock | |
| Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 115,000 | 115,000 | - | - | Non-qualified stock option (Right to Buy) | |
| Select Medical Holdings Corp | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 10,000 | 66,000 (0%) | 0% | 0 | Common Stock | |
| Select Medical Holdings Corp | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 10,000 | 56,000 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Select Medical Holdings Corp | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 10,000 | 46,000 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Select Medical Holdings Corp | Daniel J. Thomas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 6,000 | 36,000 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 23,500 | 23,500 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Thomas O. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 8,300 | 8,300 | - | - | Stock Option (right to buy) |